Read the Beforeitsnews.com story here. Advertise at Before It's News here.
Profile image
By Streetwise Reports (Reporter)
Contributor profile | More stories
Story Views
Now:
Last hour:
Last 24 hours:
Total:

Fortuna Sells a Second Mine in Short Order

% of readers think this story is Fact. Add your two cents.


Source: Adrian Day 04/25/2025

Global Analyst Adrian Day reviews recent developments at some of the companies on his list.

Fortuna Mining Corp. (FSM:NYSE; FVI:TSX; FVI:BVL; F4S:FSE) announced it had completed the on-again, off-again sale of San Jose Mine in Mexico. The new buyer is a private Peruvian company. This comes hard on the heels of the sale of its Yaramoko Mine in Burkina Faso. Both mines were approach the end of their mine lives. Although the sale of Yaramoko will cut the company’s expected production to around 350,000 ounces this year, San Jose was not included in the company’s earlier guidance, so it will have no effect on production.

Fortuna retains a 1% royalty on production of gold and silver above 119,000 GEOs. Fortuna is now looking for mines to replace the two sold. With a solid balance sheet, conservative management, and three great mines in Peru, Argentina, and Cȏte d/Ivoire (plus a good development project in Senegal), Fortuna is one of our top picks among producers.

Given the run-up in the share price and the reduction in anticipated production for the year, we are holding and will buy again on a pullback.

Insiders Step Up Buying of Lara Amid Optimism on Copper Project

Lara Exploration Ltd. (LRA:TSX.V) has seen ongoing insider buying, culminating in a purchase of 120,000 shares a week ago by Christopher MacIntyre, Vice President of Corporate Development. These shares were purchased at $1.50, which was, at that time, not far from the all-time highs for the stock price, and follows further buying this year both from Mr. MacIntyre and other officers, including the Chairman Miles Thompson and CEO Simon Ingram and a director; together, management and directors now hold almost 20% of the shares.

The company owns the Planalto copper project in the Carajas region of Brazil. BHP is currently conducting a sale of its assets in the region, and companies looking at acquiring those might also be interested in Planalto. A PEA is expected within six months and the mine could be in production within five years, a short time frame for a copper mine at a time when there is a shortage of copper projects. Insider buying in the market is always a strong sign.

The stock is up 66% in the past two weeks, but we consider it still a Buy.

Altius Revenue Up, Awaiting News on Silicon Royalty

Altius Minerals Corp. (ALS:TSX) reported revenue of almost $15 million for the first quarter, up from the fourth though down moderately from the year-ago quarter.

The gains over the fourth quarter were entirely attributable to higher revenue from the base and battery metals division, which in turn was mostly due to the timing of copper deliveries from Chapada; all other sectors saw revenue fall.

Compared with a year ago, base and battery metals saw an increase, as did iron ore, though potash revenue fell meaningfully, partly due the annual maintenance closure at one mine.

Will Altius Keep the Silicon Royalty?

If we do not hear anything before then, I am sure that when the company reports full quarterly financials a month from now, there will be discussion on the potential sale of Altius’ Silicon-Merlin royalty. Given that the arbitration decision on the key areas was made in January, and an expected resource update was announced by Anglo in mid March, we would have expected some announcement by now.

The fact that there has not been suggests to me that the offers made so far are neither so good as to be accepted nor so bad as to be dismissed. It would indicate that discussions are ongoing. (This is my inference not something that I know with certainty.) Though I believe a decision to keep the royalty would be positive for Altius, the failure to obtain a sufficiently good price would likely be viewed, initially, as a disappointment in the market. Altius is a core holding for broad exposure to commodities.

The stock may slip a little further in coming weeks, though if you do not own it, this is a good time and price to be buying.

Mali Government May Confiscate Mine

Barrick Gold Corp. (ABX:TSX; GOLD:NYSE) confirmed that its head office in Mali had been closed by the government, ramping up the dispute over alleged back taxes and a future revenue sharing agreement. The government threatened to take over Barrick’s shuttered LouloGounkoto mine. The dispute came to a head when the government stole three tonnes of gold from the company and jailed several employees. Barrick states that an agreement was reached which they signed but that the government has not yet signed it.

It says it continues to engage in good faith, suggesting that the finalization of the agreement was being obstructed by a small group of people in the Mali government. It said it had continued to pay wages to its workers, adding “this situation is not sustainable for the longer term.”

However, Barrick has been moving employees from Mali to its mines in the Congo, suggesting that no resolution to the dispute is imminent. It said it was prepared to pursue legal remedies.

Hold.

TOP BUYS this week, in addition to above, include Ares Capital Corp. (ARCC:NASDAQ), Kingsmen Creatives Ltd. (KMEN:SI), Hutchison Port Holdings Trust (HPHT:Singapore), Midland Exploration Inc. (MD:TSX.V), and Fox River Resources Corp. (FOX:CSE).

Sign up for our FREE newsletter at: www.streetwisereports.com/get-news

Important Disclosures:

  1. As of the date of this article, officers and/or employees of Streetwise Reports LLC (including members of their household) own securities of Fortuna Mining Corp., Lara Exploration Ltd., Altius Minerals Corp., Barrick Gold Corp., Midland Exploration Inc., and Fox River Resources Corp.
  2. Adrian Day: I, or members of my immediate household or family, own securities of: All. My company has a financial relationship with: All. I determined which companies would be included in this article based on my research and understanding of the sector.
  3. Statements and opinions expressed are the opinions of the author and not of Streetwise Reports, Street Smart, or their officers. The author is wholly responsible for the accuracy of the statements. Streetwise Reports was not paid by the author to publish or syndicate this article. Streetwise Reports requires contributing authors to disclose any shareholdings in, or economic relationships with, companies that they write about. Any disclosures from the author can be found below. Streetwise Reports relies upon the authors to accurately provide this information and Streetwise Reports has no means of verifying its accuracy.
  4. This article does not constitute investment advice and is not a solicitation for any investment. Streetwise Reports does not render general or specific investment advice and the information on Streetwise Reports should not be considered a recommendation to buy or sell any security. Each reader is encouraged to consult with his or her personal financial adviser and perform their own comprehensive investment research. By opening this page, each reader accepts and agrees to Streetwise Reports’ terms of use and full legal disclaimer. Streetwise Reports does not endorse or recommend the business, products, services or securities of any company.

For additional disclosures, please click here.

Adrian Day Disclosures

Adrian Day’s Global Analyst is distributed for $990 per year by Investment Consultants International, Ltd., P.O. Box 6644, Annapolis, MD 21401. (410) 224-8885. www.AdrianDayGlobalAnalyst.com. Publisher: Adrian Day. Owner: Investment Consultants International, Ltd. Staff may have positions in securities discussed herein. Adrian Day is also President of Global Strategic Management (GSM), a registered investment advisor, and a separate company from this service. In his capacity as GSM president, Adrian Day may be buying or selling for clients securities recommended herein concurrently, before or after recommendations herein, and may be acting for clients in a manner contrary to recommendations herein. This is not a solicitation for GSM. Views herein are the editor’s opinion and not fact. All information is believed to be correct, but its accuracy cannot be guaranteed. The owner and editor are not responsible for errors and omissions. © 2023. Adrian Day’s Global Analyst. Information and advice herein are intended purely for the subscriber’s own account. Under no circumstances may any part of a Global Analyst e-mail be copied or distributed without prior written permission of the editor. Given the nature of this service, we will pursue any violations aggressively.

( Companies Mentioned: ALS:TSX, ABX:TSX; GOLD:NYSE, FSM:NYSE; FVI:TSX; FVI:BVL; F4S:FSE, LRA:TSX.V, )


Source: https://www.streetwisereports.com/article/2025/04/25/fortuna-sells-a-second-mine-in-short-order.html


Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world.

Anyone can join.
Anyone can contribute.
Anyone can become informed about their world.

"United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.

Before It’s News® is a community of individuals who report on what’s going on around them, from all around the world. Anyone can join. Anyone can contribute. Anyone can become informed about their world. "United We Stand" Click Here To Create Your Personal Citizen Journalist Account Today, Be Sure To Invite Your Friends.


LION'S MANE PRODUCT


Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules


Mushrooms are having a moment. One fabulous fungus in particular, lion’s mane, may help improve memory, depression and anxiety symptoms. They are also an excellent source of nutrients that show promise as a therapy for dementia, and other neurodegenerative diseases. If you’re living with anxiety or depression, you may be curious about all the therapy options out there — including the natural ones.Our Lion’s Mane WHOLE MIND Nootropic Blend has been formulated to utilize the potency of Lion’s mane but also include the benefits of four other Highly Beneficial Mushrooms. Synergistically, they work together to Build your health through improving cognitive function and immunity regardless of your age. Our Nootropic not only improves your Cognitive Function and Activates your Immune System, but it benefits growth of Essential Gut Flora, further enhancing your Vitality.



Our Formula includes: Lion’s Mane Mushrooms which Increase Brain Power through nerve growth, lessen anxiety, reduce depression, and improve concentration. Its an excellent adaptogen, promotes sleep and improves immunity. Shiitake Mushrooms which Fight cancer cells and infectious disease, boost the immune system, promotes brain function, and serves as a source of B vitamins. Maitake Mushrooms which regulate blood sugar levels of diabetics, reduce hypertension and boosts the immune system. Reishi Mushrooms which Fight inflammation, liver disease, fatigue, tumor growth and cancer. They Improve skin disorders and soothes digestive problems, stomach ulcers and leaky gut syndrome. Chaga Mushrooms which have anti-aging effects, boost immune function, improve stamina and athletic performance, even act as a natural aphrodisiac, fighting diabetes and improving liver function. Try Our Lion’s Mane WHOLE MIND Nootropic Blend 60 Capsules Today. Be 100% Satisfied or Receive a Full Money Back Guarantee. Order Yours Today by Following This Link.


Report abuse

Comments

Your Comments
Question   Razz  Sad   Evil  Exclaim  Smile  Redface  Biggrin  Surprised  Eek   Confused   Cool  LOL   Mad   Twisted  Rolleyes   Wink  Idea  Arrow  Neutral  Cry   Mr. Green

MOST RECENT
Load more ...

SignUp

Login

Newsletter

Email this story
Email this story

If you really want to ban this commenter, please write down the reason:

If you really want to disable all recommended stories, click on OK button. After that, you will be redirect to your options page.